Cargando…

Reducing farnesyl diphosphate synthase levels activates Vγ9Vδ2 T cells and improves tumor suppression in murine xenograft cancer models

Human Vγ9Vδ2 T cells are attractive candidates for cancer immunotherapy due to their potent capacity for tumor recognition and cytolysis of many tumor cell types. However, efforts to deploy clinical strategies for Vγ9Vδ2 T cell cancer therapy are hampered by insufficient potency. We are pursuing an...

Descripción completa

Detalles Bibliográficos
Autores principales: Liou, Mei-Ling, Lahusen, Tyler, Li, Haishan, Xiao, Lingzhi, Pauza, C. David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581136/
https://www.ncbi.nlm.nih.gov/pubmed/36275712
http://dx.doi.org/10.3389/fimmu.2022.1012051